Portal de investigação
Increased Risk of Heart Failure Hospitalization With GLP-1 Receptor Agonists in Patients With Reduced Ejection Fraction: A Meta-Analysis of the EXSCEL and FIGHT Trials.
Autores da FMUP
Participantes de fora da FMUP
- Packer, M
Unidades de investigação
Abstract
Filiações
Filiações não disponíveis
Proyectos asociados
Dapagliflozin, Spironolactone or Both for HFpEF (SOGALDI-PEF) - NCT05676684
Investigador Principal: João Pedro Melo Marques Pinho Ferreira
Ensaio Clínico Académico (SOGALDI-PEF) . AstraZeneca . 2022
Evaluation of thyroid function in patients hospitalized for acute heart failure
Investigador Principal: João Sérgio de Lima Soares Neves
Estudo Clínico Académico (Heart failure) . 2021
Predictors Of The Effectiveness Of Insulin Pumps In Patiens With Type 1 Diabetes Mellitus
Investigador Principal: João Sérgio de Lima Soares Neves
Estudo Clínico Académico . 2021
Impacto da pandemia COVID-19 no controlo metabólico de doentes com Diabetes Mellitus Tipo 1
Investigador Principal: João Sérgio de Lima Soares Neves
Estudo Clínico Académico . 2022
Influence of Diabetes on Response to Ultrasound Guided Hydrodistension Treatment of Adhesive Capsulitis: a Retrospective Study
Investigador Principal: João Sérgio de Lima Soares Neves
Estudo Clínico Académico (Hydrodistension ) . 2022
Influence of Cystic Fibrosis-Related Diabetes on the Severity of Cystic Fibrosis Phenotype
Investigador Principal: João Sérgio de Lima Soares Neves
Estudo Clínico Académico . 2022
Citar a publicação
Neves JS,Packer M,Ferreira JP. Increased Risk of Heart Failure Hospitalization With GLP-1 Receptor Agonists in Patients With Reduced Ejection Fraction: A Meta-Analysis of the EXSCEL and FIGHT Trials. J. Card. Fail. 2023. 29. (7):p. 1107-1109. IF:6,000. (1).
